BCN-NODAGA
BCN-NODAGA is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].
Product Specifications
CAS Number
2256055-98-6
UNSPSC
12352203
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcn-nodaga.html
Smiles
OC([C@@H](N1CCN(CCN(CC1)CC(O)=O)CC(O)=O)CCC(NCCNC(OC[C@H]2[C@]3([H])[C@@]2([H])CCC#CCC3)=O)=O)=O
Molecular Formula
C28H43N5O9
Molecular Weight
593.67
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
RDC Bifunctional Chelator
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2132354-01 0.1 mL
Cy3 Linked Monoclonal Antibody to Cluster Of Differentiation 8a (CD8a)
Sign In for Pricing
View Details MBS2132354-02 0.2 mL
Cy3 Linked Monoclonal Antibody to Cluster Of Differentiation 8a (CD8a)
Sign In for Pricing
View Details MBS2132354-03 0.5 mL
Cy3 Linked Monoclonal Antibody to Cluster Of Differentiation 8a (CD8a)
Sign In for Pricing
View Details MBS2132354-04 1 mL
Cy3 Linked Monoclonal Antibody to Cluster Of Differentiation 8a (CD8a)
Sign In for Pricing
View Details MBS2132354-05 5 mL
Cy3 Linked Monoclonal Antibody to Cluster Of Differentiation 8a (CD8a)
Sign In for Pricing
View Details